OptimizeRx.png
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
24 févr. 2021 16h01 HE | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported...
OptimizeRx.png
OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List
23 févr. 2021 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients,...
OptimizeRx.png
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET
18 févr. 2021 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will...
OptimizeRx.png
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021
16 févr. 2021 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has...
OptimizeRx.png
OptimizeRx Announces Pricing of Public Offering of Common Stock
09 févr. 2021 09h10 HE | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and...
OptimizeRx.png
OptimizeRx Announces Proposed Public Offering of Common Stock
08 févr. 2021 16h18 HE | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and...
OptimizeRx.png
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million
25 janv. 2021 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Jan. 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported...
OptimizeRx.png
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
21 janv. 2021 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been...
OptimizeRx.png
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
06 janv. 2021 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been...
OptimizeRx.png
OptimizeRx’s TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360
11 déc. 2020 07h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Dec. 11, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its...